Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting-Reference-Cited by-同舟云学术

Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting

Published:2022-08 Issue:6 Volume:6 Page:e12777
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Zwagemaker Anne‐Fleur,Kloosterman Fabienne R.^ORCID,Coppens Michiel^ORCID,Gouw Samantha C.^ORCID,Boyce Sara^ORCID,Bagot Catherine N.^ORCID,Beckers Erik A.M.^ORCID,Brons Paul^ORCID,Castaman Giancarlo^ORCID,Eikenboom Jeroen^ORCID,Jackson Shannon^ORCID,Kruip Marieke J.H.A.^ORCID,Leebeek Frank W.G.^ORCID,Meijer Karina^ORCID,Nieuwenhuizen Laurens^ORCID,Pabinger Ingrid^ORCID,Fijnvandraat Karin^ORCID

Funder

Novo Nordisk

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12777

Reference31 articles.

1. 1‐Deamino‐8‐d‐arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases;Mannucci;Lancet,1977

2. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP);Kaufmann;J Thromb Haemost,2003

3. Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A;Castaman;J Thromb Haemost,2009